Hakutulokset - Huber, Reid

The effect of long-term ruxolitinib treatment on JAK2p.V617F allele burden in patients with myelofibrosis Tekijä Deininger, Michael, Radich, Jerald, Burn, Timothy C., Huber, Reid, Paranagama, Dilan, Verstovsek, Srdan

Hae kokoteksti Hae kokoteksti Hae kokoteksti

CCR2 modulates inflammatory and metabolic effects of high-fat feeding Tekijä Weisberg, Stuart P., Hunter, Deborah, Huber, Reid, Lemieux, Jacob, Slaymaker, Sarah, Vaddi, Kris, Charo, Israel, Leibel, Rudolph L., Ferrante, Anthony W.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

CCR2 modulates inflammatory and metabolic effects of high-fat feeding Tekijä Weisberg, Stuart P., Hunter, Deborah, Huber, Reid, Lemieux, Jacob, Slaymaker, Sarah, Vaddi, Kris, Charo, Israel, Leibel, Rudolph L., Ferrante, Anthony W.

Hae kokoteksti Hae kokoteksti

DNA methylation in transcriptional repression of two differentially expressed X-linked genes, GPC3 and SYBL1 Tekijä Huber, Reid, Hansen, R. Scott, Strazzullo, Maria, Pengue, Gina, Mazzarella, Richard, D’Urso, Michele, Schlessinger, David, Pilia, Giuseppe, Gartler, Stanley M., D’Esposito, Maurizio

Hae kokoteksti Hae kokoteksti

The 11-β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy Tekijä Rosenstock, Julio, Banarer, Salomon, Fonseca, Vivian A., Inzucchi, Silvio E., Sun, William, Yao, Wenqing, Hollis, Gregory, Flores, Robert, Levy, Richard, Williams, William V., Seckl, Jonathan R., Huber, Reid

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies Tekijä Koblish, Holly, Li, Yun-long, Shin, Niu, Hall, Leslie, Wang, Qian, Wang, Kathy, Covington, Maryanne, Marando, Cindy, Bowman, Kevin, Boer, Jason, Burke, Krista, Wynn, Richard, Margulis, Alex, Reuther, Gary W., Lambert, Que T., Dostalik Roman, Valerie, Zhang, Ke, Feng, Hao, Xue, Chu-Biao, Diamond, Sharon, Hollis, Greg, Yeleswaram, Swamy, Yao, Wenqing, Huber, Reid, Vaddi, Kris, Scherle, Peggy

Hae kokoteksti Hae kokoteksti Hae kokoteksti

INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models Tekijä Liu, Phillip C. C., Koblish, Holly, Wu, Liangxing, Bowman, Kevin, Diamond, Sharon, DiMatteo, Darlise, Zhang, Yue, Hansbury, Michael, Rupar, Mark, Wen, Xiaoming, Collier, Paul, Feldman, Patricia, Klabe, Ronald, Burke, Krista A., Soloviev, Maxim, Gardiner, Christine, He, Xin, Volgina, Alla, Covington, Maryanne, Ruggeri, Bruce, Wynn, Richard, Burn, Timothy C., Scherle, Peggy, Yeleswaram, Swamy, Yao, Wenqing, Huber, Reid, Hollis, Gregory

Hae kokoteksti Hae kokoteksti Hae kokoteksti

A human CD137×PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade Tekijä Geuijen, Cecile, Tacken, Paul, Wang, Liang-Chuan, Klooster, Rinse, van Loo, Pieter Fokko, Zhou, Jing, Mondal, Arpita, Liu, Yao-bin, Kramer, Arjen, Condamine, Thomas, Volgina, Alla, Hendriks, Linda J. A., van der Maaden, Hans, Rovers, Eric, Engels, Steef, Fransen, Floris, den Blanken-Smit, Renate, Zondag-van der Zande, Vanessa, Basmeleh, Abdul, Bartelink, Willem, Kulkarni, Ashwini, Marissen, Wilfred, Huang, Cheng-Yen, Hall, Leslie, Harvey, Shane, Kim, Soyeon, Martinez, Marina, O’Brien, Shaun, Moon, Edmund, Albelda, Steven, Kanellopoulou, Chrysi, Stewart, Shaun, Nastri, Horacio, Bakker, Alexander B. H., Scherle, Peggy, Logtenberg, Ton, Hollis, Gregory, de Kruif, John, Huber, Reid, Mayes, Patrick A., Throsby, Mark

Hae kokoteksti Hae kokoteksti Hae kokoteksti